09 July 2021 : Clinical Research
Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China
Chunmei Ye12BCEF, Weiwei Chen3EF, Qi Gao12B, Yanxia Chen4B, Xiaolu Song5B, Sujie Zheng2C, Jinlin Liu2AEG*DOI: 10.12659/MSM.930241
Med Sci Monit 2021; 27:e930241
Table 4 Death rate of multiple myeloma patients with or without secondary immunodeficiency at 1 year and 3 years.
| IgG <5 g/L (n=45) | IgG ≥5 g/L (n=103) | |
|---|---|---|
| Death at 1 year (no./rate) | 15 (33.33) | 13 (12.62) |
| Death at 3 years (no./rate) | 23 (51.11) | 24 (23.30) |
| All data are presented with no. (%). | ||